摘要 |
Phosphatidylinositol (PI) 3-kinase inhibitor compounds (I), their pharmaceutically acceptable salts, and prodrugs thereof; compositions of the new compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier; and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases characterized by the abnormal activity of growth factors, protein serine/threonine kinases, and phospholipid kinases. |
申请人 |
BURGER MATTHEW;NI ZHI-JIE;PECCHI SABINA;ATALLAH GORDANA;BARTULIS SARAH;FRAZIER KELLY;SMITH AARON;VERHAGEN JOELLE;ZHANG YANCHEN;WAGMAN ALLAN;NG SIMON;PFISTER KEITH;POON DANIEL;LOUIE ALICIA;PICK TERESA;BARSANTI PAUL;IWANOWICZ EDWIN;FANTL WENDY;HENDRICKSON THOMAS;KNAPP MARK;MERRITT HANNE;VOLIVA CHARLES;WIESMANN MARION;XIN XIAOHUA;NOVARTIS AG |
发明人 |
BURGER MATTHEW;NI ZHI-JIE;PECCHI SABINA;ATALLAH GORDANA;BARTULIS SARAH;FRAZIER KELLY;SMITH AARON;VERHAGEN JOELLE;ZHANG YANCHEN;WAGMAN ALLAN;NG SIMON;PFISTER KEITH;POON DANIEL;LOUIE ALICIA;PICK TERESA;BARSANTI PAUL;IWANOWICZ EDWIN;FANTL WENDY;HENDRICKSON THOMAS;KNAPP MARK;MERRITT HANNE;VOLIVA CHARLES;WIESMANN MARION;XIN XIAOHUA |